BR0110616A - Sequências de nucleotìdeos envolvidas no aumento ou diminuição da taxa de ovulação em mamìferos - Google Patents

Sequências de nucleotìdeos envolvidas no aumento ou diminuição da taxa de ovulação em mamìferos

Info

Publication number
BR0110616A
BR0110616A BR0110616-3A BR0110616A BR0110616A BR 0110616 A BR0110616 A BR 0110616A BR 0110616 A BR0110616 A BR 0110616A BR 0110616 A BR0110616 A BR 0110616A
Authority
BR
Brazil
Prior art keywords
mammals
increasing
ovulation rate
female
nucleotide sequences
Prior art date
Application number
BR0110616-3A
Other languages
English (en)
Portuguese (pt)
Inventor
George Henry Davis
Susan May Galloway
Kenneth Pattrick Mcnatty
Olli Visa-Pekka Ritvos
Original Assignee
Agres Ltd
Olli Visa-Pekka Ritvos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agres Ltd, Olli Visa-Pekka Ritvos filed Critical Agres Ltd
Publication of BR0110616A publication Critical patent/BR0110616A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0110616-3A 2000-05-05 2001-05-04 Sequências de nucleotìdeos envolvidas no aumento ou diminuição da taxa de ovulação em mamìferos BR0110616A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ500844A NZ500844A (en) 2000-05-05 2000-05-05 Nucleotide sequences (mutated GDF-9B polypeptides) involved in increasing and decreasing mammalian ovulation rate
PCT/NZ2001/000073 WO2001085926A2 (en) 2000-05-05 2001-05-04 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate

Publications (1)

Publication Number Publication Date
BR0110616A true BR0110616A (pt) 2004-04-06

Family

ID=19927611

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110616-3A BR0110616A (pt) 2000-05-05 2001-05-04 Sequências de nucleotìdeos envolvidas no aumento ou diminuição da taxa de ovulação em mamìferos

Country Status (15)

Country Link
US (1) US20040092007A1 (https=)
EP (1) EP1292674B1 (https=)
JP (1) JP2003532414A (https=)
CN (1) CN1436237A (https=)
AR (1) AR028411A1 (https=)
AT (1) ATE401403T1 (https=)
AU (2) AU6082101A (https=)
BR (1) BR0110616A (https=)
CA (1) CA2408051A1 (https=)
DE (1) DE60134852D1 (https=)
MX (1) MXPA02010868A (https=)
NZ (1) NZ500844A (https=)
RU (1) RU2283866C2 (https=)
WO (1) WO2001085926A2 (https=)
ZA (1) ZA200208963B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate
BRPI0518900A2 (pt) * 2004-12-02 2008-12-16 Agres Ltd modulaÇço de ovulaÇço
ATE487800T1 (de) * 2005-09-13 2010-11-15 Neocodex S L Verfahren zum in-vitro-nachweis einer veranlagung zur entwicklung von veränderungen der ovarienfunktion
ES2338960B1 (es) * 2007-11-23 2011-04-19 Carnes Oviaragon S.C.L. Procedimiento de mejora de la productividad en ganado ovino.
CN105210981B (zh) * 2015-09-15 2018-09-28 中国科学院生物物理研究所 建立可应用于人类疾病研究的雪貂模型的方法及其应用
CN105941325A (zh) * 2016-06-17 2016-09-21 安徽省农业科学院畜牧兽医研究所 小尾寒羊母羊与澳洲白公羊杂交生产澳寒杂交母羊的方法
CN106614366A (zh) * 2016-12-29 2017-05-10 李振民 一种无抗生猪养殖方法
CN108753835A (zh) * 2018-05-30 2018-11-06 中山大学 一种利用CRISPR/Cas9编辑猪BMP15基因的方法
CN111440879A (zh) * 2020-04-27 2020-07-24 内蒙古大学 一种利用gdf9基因提高蒙古羊繁殖力的方法
CN111500744A (zh) * 2020-04-27 2020-08-07 内蒙古大学 一种基于gdf9基因编码区突变的蒙古羊繁殖力提高方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions

Also Published As

Publication number Publication date
ATE401403T1 (de) 2008-08-15
NZ500844A (en) 2003-06-30
MXPA02010868A (es) 2004-09-06
ZA200208963B (en) 2004-07-26
AU2001260821B2 (en) 2006-04-13
EP1292674A2 (en) 2003-03-19
WO2001085926A2 (en) 2001-11-15
CN1436237A (zh) 2003-08-13
CA2408051A1 (en) 2001-11-15
RU2283866C2 (ru) 2006-09-20
EP1292674B1 (en) 2008-07-16
US20040092007A1 (en) 2004-05-13
AU6082101A (en) 2001-11-20
WO2001085926A3 (en) 2002-08-08
AR028411A1 (es) 2003-05-07
DE60134852D1 (de) 2008-08-28
JP2003532414A (ja) 2003-11-05

Similar Documents

Publication Publication Date Title
BR0110616A (pt) Sequências de nucleotìdeos envolvidas no aumento ou diminuição da taxa de ovulação em mamìferos
Rosendahl et al. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis
ES2383970T3 (es) Fragmentación enzimática diferencial
Handel et al. Epigenetics: molecular mechanisms and implications for disease
Shi et al. Single sperm typing demonstrates that reduced recombination is associated with the production of aneuploid 24, XY human sperm
Stöger et al. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1
Budny et al. Novel missense mutations in the ubiquitination‐related gene UBE2A cause a recognizable X‐linked mental retardation syndrome
Yokomine et al. Evolution of the vertebrate DNMT3 gene family: a possible link between existence of DNMT3L and genomic imprinting
Coenye et al. Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting
Hitchins Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility
Conn et al. A functional ribosomal RNA tertiary structure involves a base triple interaction
Yamasaki-Ishizaki et al. Role of DNA methylation and histone H3 lysine 27 methylation in tissue-specific imprinting of mouse Grb10
Wang et al. Polymorphisms of the mannose binding lectin gene in patients with Sjögren's syndrome
Biswas et al. Stimulation of RTH1 nuclease of the yeast Saccharomyces cerevisiae by replication protein A
Brown The fragile X syndrome
Turker et al. A partial methylation profile for a CpG site is stably maintained in mammalian tissues and cultured cell lines
Dong et al. Mutational studies of human DNA polymerase alpha. Serine 867 in the second most conserved region among alpha-like DNA polymerases is involved in primer binding and mispair primer extension.
Metzelaar-Blok et al. Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients
Marcus et al. Mutation analysis and prenatal diagnosis in a Lesch-Nyhan family showing non-random X-inactivation interfering with carrier detection tests
Whitcomb The spectrum of complications of hereditary pancreatitis: Is this a model for future gene therapy?
Bourdon et al. Evidence of somatic mosaicism for aMECP2 mutation in females with Rett syndrome: diagnostic implications
ATE246731T1 (de) Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten
Gow et al. A high incidence of clustered microsatellite mutations revealed by parent-offspring analysis in the African freshwater snail, Bulinus forskalii (Gastropoda, Pulmonata)
ATE315104T1 (de) Glaukom diagnose und behandlung
Orozco et al. Frequency of delta F508 in a Mexican sample of cystic fibrosis patients.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BIOTECHVISIONS LTD. (FI) , OVITA LIMITED (NZ)

Free format text: TRANSFERIDO DE: AGRESEARCH LIMITED E OLLI-VISA-PEKKA RITVOS

B25A Requested transfer of rights approved

Owner name: BIOTECHVISIONS LTD. (FI) , AGRESEARCH LIMITED (NZ)

Free format text: TRANSFERIDO DE: OVITA LIMITED

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A,9A E 10A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.